InvestorsHub Logo
Sticky
NASDAQ2020

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
DSherman Free
20 minutes ago
profile icon
DSherman Free
21 minutes ago
profile icon
rocioyogi Free
48 minutes ago
Bullish
Bullish

Elite Pharmaceuticals Inc (ELTP) RSS Feed

Followers
969
Posters
Posts (Today)
255
Posts (Total)
402991
Created
03/24/09
Type
Free
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci

 

Fiscal Year: 2024
Revenue: $56,625,128
Change: +65.79%
Net Income: $20,108,631
Change: +464.56%
 
 



 


Senior Moderator: IB_
Posted: 7/02/2024

________________________________________________________________________________________________________________


Elite Pharmaceuticals, Inc.
 

Website

Location

Employees

Facility

CEO
www.elitepharma.com
 
Northvale, New Jersey
 
64
 
55,000 sq ft
 
Nasrat Hakim
 
 
 
Products & Pipeline
 

Drug

Market Size

Status

Competitors

Marketed By
Adderall IR 389.8 M On Market 15 Elite
Adderall XR 1.56 B On Market 10 Elite & Prasco
Dantrolene 6.3 M On Market 2 Elite
Isradipine 5.5 M On Market 1 Elite
Loxapine 5 M On Market 2 Elite
Phendimetrazine 4.5 M On Market 4 Elite
Trimipramine 2 M On Market 1 Elite
Naltrexone 16 M On Market 5 Precision Dose
Phentermine Capsules 7.5 M On Market 6 Precision Dose
Phentermine Tablets 40 M On Market 8 Precision Dose
Vigabatrin 233.7 M On Market 13 Pyros
Doxycycline 85 M Approved (Discontinued) 9 ----------
Tylenol with Codeine 45 M Approved  5 ----------
Dopamine Agonist 12 M Filed with FDA - 22 Dec 2022 ---------- ----------
Methotrexate 64.3M Approved - 16 May 2024 8 Elite
Percocet 500 M Approved    ----------
Norco 477 M Approved    ----------
Methadone 30 M Approved    ----------
 OxyContin 720 M Filed with FDA - 17 Aug 2023 ---------- ----------
 Vyvanse 5.1 B Filed with FDA - 21 Dec 2023 14 ----------
 Concerta 1.16 B In Development (Final Stages) 9 ----------
         
 
 
Financials
 

Fiscal Year

Revenue

Change

Net Income

Change
2019 7,568,508 ---------- (9,279,321) ----------
2020 17,994,639 +137.76% (2,240,351) +75.86%
2021 25,380,749 +41.05% 5,088,421 +327.13%
2022 32,262,117 +27.11% 8,898,245 +74.87%
2023 34,155,114 +5.87% 3,561,846 -59.97%
2024 56,625,128 +65.79% 20,108,631 +464.56%
         
         
         
         
 

 

Chart
 


 

Board Manager:  Dr JoeBarducci
Last Updated:  Jun 22, 2024

 
Top Posts With Reactions
(Last 30 Days)
profile-icon
Pharma Sleuth 06/07/24 4:53 PM
🌴
👍️
👑
30
profile-icon
namtae 06/24/24 1:27 PM
🐐
👍️
👺
19
profile-icon
rrr2003 06/22/24 5:56 PM
👍️
👏
💥
18
profile-icon
Dr JoeBarducci 06/02/24 7:17 PM
👍️
👑
💥
18
profile-icon
The ELTP King 7 hours ago
🐐
👍️
👑
17
profile-icon
Winechemist 11 hours ago
👍️
👑
💎
17
profile-icon
Dr JoeBarducci 06/29/24 7:31 AM
👍️
👏🏻
💯
17
profile-icon
HGilS 06/21/24 6:02 PM
👍️
💥
16
profile-icon
kayak_wench 6 hours ago
👍️
👑
💎
15
profile-icon
WeeZuhl 06/25/24 9:37 AM
👍️
👏🏻
👑
15
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
ELTP Latest News
New Post